These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 9822281)
1. Processing of the DRB1*1103-restricted measles virus nucleoprotein determinant 185-199 in the endosomal compartment. Demotz S; Ammerlaan W; Fournier P; Muller CP; Barbey C Clin Exp Immunol; 1998 Nov; 114(2):228-35. PubMed ID: 9822281 [TBL] [Abstract][Full Text] [Related]
2. Efficient MHC class II-restricted presentation of measles virus to T cells relies on its targeting to its cellular receptor human CD46 and involves an endosomal pathway. Gerlier D; Trescol-Biémont MC; Varior-Krishnan G; Naniche D; Fugier-Vivier I; Rabourdin-Combe C Cell Biol Int; 1994 May; 18(5):315-20. PubMed ID: 8049676 [TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides. Ovsyannikova IG; Johnson KL; Muddiman DC; Vierkant RA; Poland GA J Virol; 2004 Jan; 78(1):42-51. PubMed ID: 14671086 [TBL] [Abstract][Full Text] [Related]
4. Formaldehyde inactivation of measles virus abolishes CD46-dependent presentation of nucleoprotein to murine class I-restricted CTLs but not to class II-restricted helper T cells. Cardoso AI; Beauverger P; Gerlier D; Wild TF; Rabourdin-Combe C Virology; 1995 Sep; 212(1):255-8. PubMed ID: 7676641 [TBL] [Abstract][Full Text] [Related]
5. Serotype-specific and canine distemper virus cross-reactive H-2Kk-restricted cytotoxic T lymphocyte epitopes in the measles virus nucleoprotein. Beauverger P; Chadwick J; Buckland R; Wild TF Virology; 1994 Aug; 203(1):172-7. PubMed ID: 7518168 [TBL] [Abstract][Full Text] [Related]
6. The processing routes determined by negatively charged residues in DR1-restricted T cell determinants. Robadey C; Ammerlaan W; Muller C; Cloutier I; Sékaly RP; Haefliger JA; Demotz S J Immunol; 1997 Oct; 159(7):3238-46. PubMed ID: 9317122 [TBL] [Abstract][Full Text] [Related]
7. Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system. Oxenius A; Bachmann MF; Ashton-Rickardt PG; Tonegawa S; Zinkernagel RM; Hengartner H Eur J Immunol; 1995 Dec; 25(12):3402-11. PubMed ID: 8566030 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the contribution of CTL epitopes in the immunobiology of morbillivirus infection. Beauverger P; Cardoso AI; Daviet L; Buckland R; Wild TF Virology; 1996 May; 219(1):133-9. PubMed ID: 8623522 [TBL] [Abstract][Full Text] [Related]
9. Influence of HLA-DRB1 alleles on lymphoproliferative responses to a naturally processed and presented measles virus phosphoprotein in measles immunized individuals. Ovsyannikova IG; Poland GA; Easler NJ; Vierkant RA Hum Immunol; 2004 Mar; 65(3):209-17. PubMed ID: 15041159 [TBL] [Abstract][Full Text] [Related]
10. Importance of HLA-DQ and HLA-DP polymorphisms in cytokine responses to naturally processed HLA-DR-derived measles virus peptides. Ovsyannikova IG; Vierkant RA; Poland GA Vaccine; 2006 Jun; 24(25):5381-9. PubMed ID: 16714073 [TBL] [Abstract][Full Text] [Related]
11. Processing of DR1-restricted determinants from the fusion protein of measles virus following two distinct pathways. Demotz S; Péléraux A Mol Immunol; 1996; 33(4-5):387-97. PubMed ID: 8676890 [TBL] [Abstract][Full Text] [Related]
12. Differential activation of T cells by antibody-modulated processing of the flanking sequences of class II-restricted peptides. Fournier P; Ammerlaan W; Ziegler D; Giminez C; Rabourdin-Combe C; Fleckenstein BT; Wiesmüller KH; Jung G; Schneider F; Muller CP Int Immunol; 1996 Sep; 8(9):1441-51. PubMed ID: 8921422 [TBL] [Abstract][Full Text] [Related]
13. Naturally processed measles virus peptide eluted from class II HLA-DRB1*03 recognized by T lymphocytes from human blood. Ovsyannikova IG; Johnson KL; Naylor S; Muddiman DC; Poland GA Virology; 2003 Aug; 312(2):495-506. PubMed ID: 12919753 [TBL] [Abstract][Full Text] [Related]
14. Activation of T cells by the ragged tail of MHC class II-presented peptides of the measles virus fusion protein. Muller CP; Ammerlaan W; Fleckenstein B; Krauss S; Kalbacher H; Schneider F; Jung G; Wiesmüller KH Int Immunol; 1996 Apr; 8(4):445-56. PubMed ID: 8671631 [TBL] [Abstract][Full Text] [Related]
15. Efficient major histocompatibility complex class II-restricted presentation of measles virus relies on hemagglutinin-mediated targeting to its cellular receptor human CD46 expressed by murine B cells. Gerlier D; Trescol-Biémont MC; Varior-Krishnan G; Naniche D; Fugier-Vivier I; Rabourdin-Combe C J Exp Med; 1994 Jan; 179(1):353-8. PubMed ID: 8270880 [TBL] [Abstract][Full Text] [Related]
16. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide. Carreno BM; Turner RV; Biddison WE; Coligan JE J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522 [TBL] [Abstract][Full Text] [Related]
17. Melanosomal targeting sequences from gp100 are essential for MHC class II-restricted endogenous epitope presentation and mobilization to endosomal compartments. Lepage S; Lapointe R Cancer Res; 2006 Feb; 66(4):2423-32. PubMed ID: 16489049 [TBL] [Abstract][Full Text] [Related]
18. Endocytic recycling is required for the presentation of an exogenous peptide via MHC class II molecules. Pathak SS; Blum JS Traffic; 2000 Jul; 1(7):561-9. PubMed ID: 11208144 [TBL] [Abstract][Full Text] [Related]
19. Measles virus antigens induce both type-specific and canine distemper virus cross-reactive cytotoxic T lymphocytes in mice: localization of a common Ld-restricted nucleoprotein epitope. Beauverger P; Buckland R; Wild TF J Gen Virol; 1993 Nov; 74 ( Pt 11)():2357-63. PubMed ID: 7504072 [TBL] [Abstract][Full Text] [Related]
20. Antigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B-lymphoblastoid cells. Voeten JT; Rimmelzwaan GF; Nieuwkoop NJ; Fouchier RA; Osterhaus AD Clin Exp Immunol; 2001 Sep; 125(3):423-31. PubMed ID: 11531950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]